News
Feed
Events
Feed
News
+ Events
Feed

Dermapharm Holding SE

  • ISIN DE000A2GS5D8
  • Country Deutschland

Latest News

29 August 2024

14:04 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

27 August 2024

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: High-margin existing business in branded pharmaceuticals segment drives organic growth at German and international companies

20 August 2024

10:00 Advance Financial Reports

Dermapharm Holding SE

Advance Financial Reports

 

14 August 2024

07:30 Corporate

Dermapharm Holding SE

Corporate

Sustained organic growth in high-margin existing branded pharmaceutical business

27 June 2024

18:15 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share

11 June 2024

10:00 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Susanne Gertrud Pia Lanz, buy

22 May 2024

10:31 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

15 May 2024

07:30 Corporate

Dermapharm Holding SE

Corporate

Strong organic growth in core markets underscores resilience of Dermapharm Holding SE’s corporate strategy

8 May 2024

08:00 Advance Financial Reports

Dermapharm Holding SE

Advance Financial Reports

 

10 April 2024

10:00 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Wilhelm Beier, buy

28 March 2024

17:45 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Anja Schorn, buy

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE fulfils all expectations despite multiple macroeconomic challenges

21 March 2024

11:20 Advance Financial Reports

Dermapharm Holding SE

Advance Financial Reports

 

14 March 2024

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE hits upper end of guidance range for adjusted EBITDA, primarily due to steadily growing international presence in branded business

23 November 2023

14:00 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Themis Beteiligungs-Aktiengesellschaft, buy

15 November 2023

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE builds on success in Q3 2023

7 November 2023

14:56 Advance Financial Reports

Dermapharm Holding SE

Advance Financial Reports

 

29 August 2023

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE publishes H1 2023 financial report, confirms outlook for 2023 overall

16 August 2023

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: First half of 2023 is a success despite the challenging market environment

6 July 2023

15:14 Voting Rights Announcements

Dermapharm Holding SE

Voting Rights Announcements

 

27 June 2023

14:30 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Dr. Hans-Georg Feldmeier, buy

14 June 2023

17:00 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 1.05 per share

13 June 2023

15:15 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE invests in family-owned Austrian pharmaceutical company Montavit

31 May 2023

14:45 Voting Rights Announcements

Dermapharm Holding SE

Voting Rights Announcements

 

15 May 2023

07:30 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: outstanding start to financial year 2023

8 May 2023

12:58 Advance Financial Reports

Dermapharm Holding SE

Advance Financial Reports

 

4 April 2023

18:28 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Benjamin Dreibholz, buy

18:23 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Katharina Dreibholz, buy

3 April 2023

17:55 Directors’ Dealings

Dermapharm Holding SE

Directors’ Dealings

Dermapharm Holding SE: Christof Dreibholz, buy

28 March 2023

07:29 Corporate

Dermapharm Holding SE

Corporate

Dermapharm Holding SE: Dermapharm Holding SE surpasses one billion in revenue for first time in 2022 and maintains growth trajectory

Upcoming Events

14

Nov 24

Dermapharm Holding SE

Publication quarterly statement (call-date Q3)